Hear more from Justin at the HPAPI
conference this April 2018, as he presents: "Strategic Management of HPAPI
2) The lack of expertise in containment chemistry led many HPAPI
manufacturers to hire external consultants to handle containment issues.
Many contract manufacturers are also building new facilities that are designed specifically for the manufacture of HPAPIs
, which require a huge investment of millions beyond typical good manufacturing practices production facilities.
Given this level of investment, Pharma was keen to learn more about why the company decided to expand its HPAPI
Discover practical approaches to HPAPI
manufacturing in a controlled and efficient manner
Designed to significantly increase production capacity for commercial scale High Potency Active Pharmaceutical Ingredients (HPAPIs
), the project includes a new 45,000 sq ft manufacturing facility with reactors capable of producing HPAPI
batch sizes up to 4000 litres.
Develop commercial potential in ADCs, as Justin Mason-Home, Director, HPAPI
Project Services Limited, will be exploring the ADC component hazards, risk assessment, communication and management.
and Anticancers, containment technologies have been engineered for handling of products.
Patent expiration of prominent drugs led to increased generic drug sales, government initiatives for biomedical research, increasing scope of the HPAPI
market, increasing aged population and regional penetration, local manufacturer expansion and high uptake of biologics are some of the factors that are driving the market growth.